Vistin Pharma ASA: Invitation to Q3 2025 conference call

24 Oct 2025 10:00 CEST

Oslo, Norway, 24 October 2025

Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on
Friday 31st of October 2025. Vistin Pharma will host a conference call for all
shareholders and interested parties on the same day at 08:30 CET. There will be
a Q&A session following the management discussion.

The conference call will be held in English.

The third quarter conference call will be available via web and audio through
the following access points:

Webcast: https://edge.media-server.com/mmc/p/zojifvb6
(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-
server.com%2Fmmc%2Fp%2Fzojifvb6&data=05%7C02%7CAlexander.Karlsen%40vistin.com%7C
a4f762044c9844b78b6f08ddf42aab61%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63
8935186643331816%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDA
wMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=W6bnr0E
m%2FU288%2BJ%2FzLaF42vyGP%2FdMZE2fvdYMjPFMQ4%3D&reserved=0)

Telephone conference (online registration):
https://register-conf.media-
server.com/register/BI4b6411bcd117427f8df81e59f7b2fd65
(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fregister-
conf.media-
server.com%2Fregister%2FBI4b6411bcd117427f8df81e59f7b2fd65&data=05%7C02%7CAlexan
der.Karlsen%40vistin.com%7Ca4f762044c9844b78b6f08ddf42aab61%7C2fcdf060b2c2456e8b
b7944b7e40981a%7C0%7C0%7C638935186643348798%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1h
cGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D
%7C0%7C%7C%7C&sdata=JaK5TpCz%2BwnMxRzZu7w%2Bg9xb3BtiG5G55gOVuohROwo%3D&reserved=
0)

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.

More information:
Access the news on Oslo Bors NewsWeb site